N-glycosylation status of β-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases

International Journal of Oncology

Volumn 36, Issue 1, 2010, Pages 193-203

  Yoon, Seon Joo ^a,e   Park, Seung Yeol ^a,b   Pang, Poh Choo ^c   Gallagher, Jenni ^d   Gottesman, James E ^d   Dell, Anne ^c   Kim, Jung Hoe ^b   Hakomori, Sen Itiroh ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Seattle Urological Associates   (United States)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Haptoglobin; Lectin blotting; Mass spectrometry; N linked glycan; Prostate cancer

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; GLYCOSIDASE; HAPTOGLOBIN; LECTIN; MONOCLONAL ANTIBODY; SIALYL LEWIS X ANTIGEN;

ACINAR CELL; ADULT; AGED; ANTIBODY AFFINITY; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LECTIN BINDING; MALE; MASS SPECTROMETRY; PHASEOLUS VULGARIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN SECRETION; SAMBUCUS NIGRA; TUMOR DIFFERENTIATION;

AGED; CHROMATOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLYCOSYLATION; HAPTOGLOBINS; HUMANS; LECTINS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PHASEOLUS; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 74549166187     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000490     Document Type: Article

References (40)

1. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318, 1996.
2. Livingston PO, Natoli EJ, Calves MJ, Stockert E, Oettgen HF and Old LJ: Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc Natl Acad Sci USA 84: 2911-2915, 1987.
3. MacLean GD, Reddish MA, Koganty RR and Longenecker BM: Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. J Immunother 19: 59-68, 1996.
4. Slovin SF, Ragupathi G, Adluri S, Ungers G, Terry K, Kim S, Spassova M, Bornmann WG, Fazzari M, Dantis L, Olkiewicz K, Lloyd KO, Livingston PO, Danishefsky SJ and Scher HI: Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc Natl Acad Sci USA 96: 5710-5715, 1999.
5. Holmberg LA, Oparin DV, Gooley T, Lilleby K, Bensinger W, Reddish MA, MacLean GD, Longenecker BM and Sandmaier BM: Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine. Bone Marrow Transplant 25: 1233-1241, 2000.
6. Livingston PO: Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale. Cancer Immunol Immunother 45: 1-9, 1997.
7. Hakomori S: Tumor-associated carbohydrate antigens defining tumor malignancy: Basis for development of anti-cancer vaccines. Adv Exp Med Biol 491: 369-402, 2001.
8. Ogata S, Muramatsu T and Kobata A: New structural characteristic of the large glycopeptides from transformed cells. Nature 259: 580-582, 1976.
9. Seelentag WKF, Li W-P, Schmitz S-FH, Metzger U, Aeberhard P, Heitz PU and Roth J: Prognostic value of b1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 58: 5559-5564, 1998.
10. Buckhaults P, Chen L, Freigen N and Pierce M: Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem 272: 19575-19581, 1997.
11. Kang R, Saito H, Ihara Y, Miyoshi E, Koyama N, Sheng Y and Taniguchi N: Transcriptional regulation of the N-acetylglucosaminyl-transferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271: 26706-26712, 1996.
12. Dennis JW and Laferté S: Oncodevelopmental expression of - GlcNAcb1-6Mana1-6Manb1-6 branching of Asn-linked oligosaccharides in human breast carcinomas. Cancer Res 49: 945-950, 1989.
13. Langlois MR and Delanghe JR: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600, 1996.
14. Turner GA: Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv Exp Med Biol 376: 231-238, 1995.
15. Thompson S and Turner GA: Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer 56: 605-610, 1987.
16. Fujimura T, Shinohara Y, Tissot B, Pang PC, Kurogochi M, Saito S, Arai Y, Sadilek M, Murayama K, Dell A, Nishimura S and Hakomori SI: Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer 122: 39-49, 2008.
17. Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H, Ishikawa O, Ito T, Kato M, Kasahara A, Kawano S, Gu J, Taniguchi N and Miyoshi E: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118: 2803-2808, 2006.
18. Nakano M, Nakagawa T, Ito T, Kitada T, Hijioka T, Kasahara A, Tajiri M, Wada Y, Taniguchi N and Miyoshi E: Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers. Int J Cancer 122: 2301-2309, 2008.
19. x. Science 250: 1130-1132, 1990.
20. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H and Ginsburg V: A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257: 14365-14369, 1982.
21. Liau CY, Chang TM, Pan JP, Chen WL and Mao SJ: Purification of human plasma haptoglobin by hemoglobin-affinity column chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 790: 209-216, 2003.
22. Sutton-Smith M and Dell A: Analysis of carbohydrates/glycoproteins by mass spectrometry. In: Cell Biology: A Laboratory Handbook. Celis JE (ed). Vol. 4, 3rd edition. Elsevier/Academic Press, San Diego, pp415-425, 2006.
23. Ceroni A, Maass K, Geyer H, Geyer R, Dell A and Haslam SM: GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 7: 1650-1659, 2008.
24. Eble JN, Sauter G, Epstein JI and Sesterhenn IA: Pathology and genetics of tumours of the urinary system and male genital organs. In: World Health Organization Classification of Tumours. Kleihues P and Sobin LH (eds). IARC Press, Lyon, pp179-184, 2004.
25. Turner GA: N-glycosylation of serum proteins in disease and its investigation using lectins. Clin Chim Acta 208: 149-171, 1992.
26. Turner GA, Skillen AW, Buamah P, Guthrie D, Welsh J, Harrison J and Kowalski A: Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers. J Clin Pathol 38: 588-592, 1985.
27. x and related carbohydrate antigens in the prostate. Hum Pathol 26: 735-739, 1995.
28. Ito A, Levery SB, Saito S, Satoh M and Hakomori S: A novel ganglioside isolated from renal cell carcinoma. J Biol Chem 276: 16695-16703, 2001.
29. 4) as a new marker for prostate cancer. Int J Cancer 115: 105-113, 2005.
30. Saito S, Murayama Y, Pan Y, Taima T, Fujimura T, Murayama K, Sadilek M, Egawa S, Ueno S, Ito A, Ishidoya S, Nakagawa H, Kato M, Satoh M, Endoh M and Arai Y: Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer. Int J Cancer 123: 633-640, 2008.
31. Pierce M, Buckhaults P, Chen L and Fregien N: Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 14: 623-630, 1997.
32. Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, Dickson RB, Lin C-Y and Taniguchi N: Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding b1-6 GlcNAc branching. J Biol Chem 277: 16960-16967, 2002.
33. Saito T, Miyoshi E, Sasai K, Nakano N, Eguchi Y, Honke K and Taniguchi N: A secreted type of b1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation. J Biol Chem 277: 17002-17008, 2002.
34. Carter HB and Partin AW: Diagnosis and staging of prostate cancer. In: Campbell's Urology. Walsh PC, Retik AB, Vaughan ED and Wein AJ (eds). Saunders, Philadelphia, pp3209-3226, 2002.
35. Gretzer MB and Partin AW: PSA markers in prostate cancer detection. Urol Clin North Am 30: 677-686, 2003.
36. Canto EI, Shariat SF and Slawin KM: Biochemical staging of prostate cancer. Urol Clin North Am 30: 263-277, 2003.
37. Haslam SM, North SJ and Dell A: Mass spectrometric analysis of N- and O-glycosylation of tissues and cells. Curr Opin Struct Biol 16: 584-591, 2006.
38. Parry S, Wong NK, Easton RL, Panico M, Haslam SM, Morris HR, Anderson P, Klotz KL, Herr JC, Diekman AB and Dell A: The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated. Glycobiology 17: 1120-1126, 2007.
39. Costello CE, Contado-Miller JM and Cipollo JF: A glycomics platform for the analysis of permethylated oligosaccharide alditols. J Am Soc Mass Spectrom 18: 1799-1812, 2007.
40. Furukawa JI, Shinohara Y, Kuramoto H, Miura Y, Shimaoka H, Kurogochi M, Nakano M and Nishimura S: Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion. Anal Chem 80: 1094-1101, 2008.